Bing Wang

Title: The Innovations of Bing Wang

Introduction

Bing Wang is a notable inventor based in Longmont, CO (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as AKT protein kinase inhibitors. His work is crucial in the fight against hyperproliferative diseases, including cancer.

Latest Patents

Bing Wang holds 1 patent related to AKT protein kinase inhibitors. The patent describes compounds that include resolved enantiomers, diastereomers, solvates, and pharmaceutically acceptable salts. These compounds are characterized by the formula: A-L-CR, where CR represents a cyclical core group, L is a linking group, and A is defined within the patent. The invention also outlines methods for using these compounds in treating various hyperproliferative diseases.

Career Highlights

Throughout his career, Bing Wang has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Array Biopharma Inc. and Genentech, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Bing Wang has collaborated with several professionals in his field, including Ian S. Mitchell and Keith Lee Spencer. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Bing Wang's contributions to the field of biochemistry, particularly through his patent on AKT protein kinase inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of cancer and other hyperproliferative diseases.